These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
135 related items for PubMed ID: 30888949
61. Giant nasal mass causing feeding difficulty in tuberous sclerosis. Lujber L, Burián A. Otolaryngol Head Neck Surg; 2011 Sep; 145(3):511-2. PubMed ID: 21602534 [No Abstract] [Full Text] [Related]
63. Cellular composition of the angiofibromas in tuberous sclerosis. Benjamin DR. Pediatr Pathol Lab Med; 1996 Oct; 16(6):893-9. PubMed ID: 9025887 [Abstract] [Full Text] [Related]
64. [Successful treatment of facial angiofibromas with local sirolimus in childhood in Bourneville-Pringle disease]. Bottyán K, Kemény L, Csoma ZR. Orv Hetil; 2019 Mar; 160(13):516-520. PubMed ID: 30907099 [Abstract] [Full Text] [Related]
65. Isolated and unilateral facial angiofibromas revealing a type 1 segmental postzygotic mosaicism of tuberous sclerosis complex with c.4949_4982del TSC2 mutation. Bessis D, Malinge MC, Girard C. Br J Dermatol; 2018 Jan; 178(1):e53-e54. PubMed ID: 29315486 [No Abstract] [Full Text] [Related]
66. Shave excision and dermabrasion for facial angiofibroma in tuberous sclerosis. Drake DB, Morgan RF, Cooper PH. Ann Plast Surg; 1992 Apr; 28(4):377-80. PubMed ID: 1317695 [Abstract] [Full Text] [Related]
67. Does the tuberous sclerosis complex include intracranial aneurysms? A case report with a review of the literature. Beltramello A, Puppini G, Bricolo A, Andreis IA, el-Dalati G, Longa L, Polidoro S, Zavarise G, Marradi P. Pediatr Radiol; 1999 Mar; 29(3):206-11. PubMed ID: 10201041 [Abstract] [Full Text] [Related]
68. Giant angiofibromas in tuberous sclerosis complex: a possible role for localized lymphedema in their pathogenesis. Kacerovska D, Kerl K, Michal M, Filipova H, Vrtel R, Vanecek T, Zelenakova H, Kraus J, Kodet R, Kazakov DV. J Am Acad Dermatol; 2012 Dec; 67(6):1319-26. PubMed ID: 22552000 [Abstract] [Full Text] [Related]
69. Effects of tranilast on angiofibromas of tuberous sclerosis. Wang L, Gao L, Abe T, Mizoguchi M. Pediatr Int; 1999 Dec; 41(6):701-3. PubMed ID: 10618896 [No Abstract] [Full Text] [Related]
70. Immunohistochemical and biochemical studies on collagen types in angiofibromas and shagreen patches from patients with tuberous sclerosis. Konomi H, Arima M, Tanaka H, Nagai Y. Brain Dev; 1982 Dec; 4(5):367-74. PubMed ID: 6291423 [Abstract] [Full Text] [Related]
71. Facial angiofibromas treated by rapamycin 0.05% ointment and a combined laser therapy. Negosanti F, Tengattini V, Gurioli C, Neri I. J Cosmet Dermatol; 2018 Oct; 17(5):762-765. PubMed ID: 30123982 [Abstract] [Full Text] [Related]
72. Cryosurgery: an easy and cheap therapy for facial angiofibromas in tuberous sclerosis. Schepis C, Siragusa M. Eur J Dermatol; 2010 Oct; 20(4):506-7. PubMed ID: 20403796 [No Abstract] [Full Text] [Related]
73. Unilateral angiofibromas. An oligosymptomatic and segmentary form of tuberous sclerosis. Del Pozo J, Martínez W, Calvo R, Almagro M, Fonseca E. Eur J Dermatol; 2002 Oct; 12(3):262. PubMed ID: 11989480 [No Abstract] [Full Text] [Related]
74. The mTOR inhibitor rapamycin significantly improves facial angiofibroma lesions in a patient with tuberous sclerosis. Hofbauer GF, Marcollo-Pini A, Corsenca A, Kistler AD, French LE, Wüthrich RP, Serra AL. Br J Dermatol; 2008 Aug; 159(2):473-5. PubMed ID: 18547304 [Abstract] [Full Text] [Related]
78. Nipple Angiofibromas with Loss of TSC2 Are Associated with Tuberous Sclerosis Complex. Nathan N, Tyburczy ME, Hamieh L, Wang JA, Brown GT, Richard Lee CC, Kwiatkowski DJ, Moss J, Darling TN. J Invest Dermatol; 2016 Feb; 136(2):535-538. PubMed ID: 26824744 [No Abstract] [Full Text] [Related]
79. Clinical and radiological findings related to tuberous sclerosis complex: a case report. Gupta S, Bhowate R, Degwekar SS. J Contemp Dent Pract; 2008 May 01; 9(4):85-91. PubMed ID: 18473031 [Abstract] [Full Text] [Related]
80. Dramatic improvement of facial angiofibromas in tuberous sclerosis with topical rapamycin: optimizing a treatment protocol. DeKlotz CM, Ogram AE, Singh S, Dronavalli S, MacGregor JL. Arch Dermatol; 2011 Sep 01; 147(9):1116-7. PubMed ID: 21931059 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]